Research ArticleArticle
Patients with Systemic Sclerosis/polymyositis Overlap Have a Worse Survival Rate Than Patients Without It
Kavish J. Bhansing, Piet L.C.M. van Riel, Baziel G.M. van Engelen, Jaap Fransen and Madelon C. Vonk
The Journal of Rheumatology August 2016, jrheum.151425; DOI: https://doi.org/10.3899/jrheum.151425
Kavish J. Bhansing
From the Department of Rheumatology, and Department of Quality of Health Care, and Department of Neurology, Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands. K.J. Bhansing, MD, Department of Rheumatology, Institute for Health Sciences, Radboud University Medical Center; P.L. van Riel, MD, PhD, Department of Quality of Health Care, Institute for Health Sciences, Radboud University Medical Center; B.G. van Engelen, MD, PhD, Department of Neurology, Institute for Health Sciences, Radboud University Medical Center; J. Fransen, PhD, Department of Rheumatology, Institute for Health Sciences, Radboud University Medical Center; M.C. Vonk, MD, PhD, Department of Rheumatology, Institute for Health Sciences, Radboud University Medical Center. Address correspondence to Dr. M.C. Vonk, Department of Rheumatology, Radboud University Medical Center, Geert Grooteplein-Zuid 8, P.O. Box 9101, 470, Nijmegen, the Netherlands. E-mail: Madelon.Vonk@radboudumc.nl. Accepted for publication June 29, 2016.
Piet L.C.M. van Riel
From the Department of Rheumatology, and Department of Quality of Health Care, and Department of Neurology, Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands. K.J. Bhansing, MD, Department of Rheumatology, Institute for Health Sciences, Radboud University Medical Center; P.L. van Riel, MD, PhD, Department of Quality of Health Care, Institute for Health Sciences, Radboud University Medical Center; B.G. van Engelen, MD, PhD, Department of Neurology, Institute for Health Sciences, Radboud University Medical Center; J. Fransen, PhD, Department of Rheumatology, Institute for Health Sciences, Radboud University Medical Center; M.C. Vonk, MD, PhD, Department of Rheumatology, Institute for Health Sciences, Radboud University Medical Center. Address correspondence to Dr. M.C. Vonk, Department of Rheumatology, Radboud University Medical Center, Geert Grooteplein-Zuid 8, P.O. Box 9101, 470, Nijmegen, the Netherlands. E-mail: Madelon.Vonk@radboudumc.nl. Accepted for publication June 29, 2016.
Baziel G.M. van Engelen
From the Department of Rheumatology, and Department of Quality of Health Care, and Department of Neurology, Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands. K.J. Bhansing, MD, Department of Rheumatology, Institute for Health Sciences, Radboud University Medical Center; P.L. van Riel, MD, PhD, Department of Quality of Health Care, Institute for Health Sciences, Radboud University Medical Center; B.G. van Engelen, MD, PhD, Department of Neurology, Institute for Health Sciences, Radboud University Medical Center; J. Fransen, PhD, Department of Rheumatology, Institute for Health Sciences, Radboud University Medical Center; M.C. Vonk, MD, PhD, Department of Rheumatology, Institute for Health Sciences, Radboud University Medical Center. Address correspondence to Dr. M.C. Vonk, Department of Rheumatology, Radboud University Medical Center, Geert Grooteplein-Zuid 8, P.O. Box 9101, 470, Nijmegen, the Netherlands. E-mail: Madelon.Vonk@radboudumc.nl. Accepted for publication June 29, 2016.
Jaap Fransen
From the Department of Rheumatology, and Department of Quality of Health Care, and Department of Neurology, Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands. K.J. Bhansing, MD, Department of Rheumatology, Institute for Health Sciences, Radboud University Medical Center; P.L. van Riel, MD, PhD, Department of Quality of Health Care, Institute for Health Sciences, Radboud University Medical Center; B.G. van Engelen, MD, PhD, Department of Neurology, Institute for Health Sciences, Radboud University Medical Center; J. Fransen, PhD, Department of Rheumatology, Institute for Health Sciences, Radboud University Medical Center; M.C. Vonk, MD, PhD, Department of Rheumatology, Institute for Health Sciences, Radboud University Medical Center. Address correspondence to Dr. M.C. Vonk, Department of Rheumatology, Radboud University Medical Center, Geert Grooteplein-Zuid 8, P.O. Box 9101, 470, Nijmegen, the Netherlands. E-mail: Madelon.Vonk@radboudumc.nl. Accepted for publication June 29, 2016.
Madelon C. Vonk
From the Department of Rheumatology, and Department of Quality of Health Care, and Department of Neurology, Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands. K.J. Bhansing, MD, Department of Rheumatology, Institute for Health Sciences, Radboud University Medical Center; P.L. van Riel, MD, PhD, Department of Quality of Health Care, Institute for Health Sciences, Radboud University Medical Center; B.G. van Engelen, MD, PhD, Department of Neurology, Institute for Health Sciences, Radboud University Medical Center; J. Fransen, PhD, Department of Rheumatology, Institute for Health Sciences, Radboud University Medical Center; M.C. Vonk, MD, PhD, Department of Rheumatology, Institute for Health Sciences, Radboud University Medical Center. Address correspondence to Dr. M.C. Vonk, Department of Rheumatology, Radboud University Medical Center, Geert Grooteplein-Zuid 8, P.O. Box 9101, 470, Nijmegen, the Netherlands. E-mail: Madelon.Vonk@radboudumc.nl. Accepted for publication June 29, 2016.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Patients with Systemic Sclerosis/polymyositis Overlap Have a Worse Survival Rate Than Patients Without It
Kavish J. Bhansing, Piet L.C.M. van Riel, Baziel G.M. van Engelen, Jaap Fransen, Madelon C. Vonk
The Journal of Rheumatology Aug 2016, jrheum.151425; DOI: 10.3899/jrheum.151425